Cellogen Therapeutics announced that it has received around $2 million in a round of funding on January 17, 2024. The transaction included participation from new investor, NATCO Pharma Limited.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,007 INR | -2.02% | +0.16% | +24.15% |
Apr. 09 | Natco Pharma Gets US FDA Warning Letter after Inspection of Kothur, India Unit | MT |
Mar. 27 | NATCO Pharma Limited Announces Board Appointments | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.45% | 2.21B | |
+25.83% | 661B | |
+26.50% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+14.81% | 231B | |
+5.01% | 200B | |
-9.00% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- NATCOPHARM Stock
- News NATCO Pharma Limited
- Cellogen Therapeutics announced that it has received $2 million in funding from NATCO Pharma Limited